AzTrials
AzTrials

Anorexia NervosaAPANORNCT04817436

Effects of Adapated Physical Activity Program on Kynurenin Metabolism During Refeeding in Anorexia Nervosa : APANOR Study

A study testing physical activity program (APA) in people with Anorexia Nervosa, run by University Hospital, Rouen at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Physical hyperactivity is often associated to anorexia nervosa (AN). Data suggest common central pathways between hyperactivity and anorexia. Maintaining adapted physical activity (APA) during refeeding in AN is controversial. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Anorexia Nervosa
What is being tested?
physical activity program (APA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteFrance
Study dates
8 Sep 2021to 8 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female
  • Patient > 18 years
  • Follow-up in the department of clinical Nutrition of Rouen
  • BMI ≥15,0 and <18,5 kg/m²
  • Diagnosis of anorexia nervosa according to DSM-V classification

Who cannot join

  • Physical activity contraindications : hemodynamic disorder, uncontrolled cardiovascular disease, intracranial hypertension
  • Patients with poor understanding of spoken or written French
  • Person deprived of their liberty by an administrative or judicial decision or person subject to a legal measure for the protection of adults
  • Person subject to a safeguard of justice, guardianship or curatorship.
  • Pregnant or breastfeeding woman

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Rouen

    Rouen, 76031

Other trials in France

About this study

Physical hyperactivity is often associated to anorexia nervosa (AN). Data suggest common central pathways between hyperactivity and anorexia. Maintaining adapted physical activity (APA) during refeeding in AN is controversial. Many studies suggest beneficits of APA in AN on body composition (increase fat free mass and better distribution of fat mass), mood regulation, bone metabolism. We recently reported benefits of maintaining physical activity during refeeding in a mice model of anorexia (activity-based anorexia model). These benefits involved the tryptophan-kynurenin pathway. Thus, we aim in the APANOR study to assess effects of APA during refeeding in AN on kynurenin metabolism.

Being tested
physical activity program (APA)
Medical subject headings
Anorexia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • physical activity program (APA)Other

    adapted physical activity program (APA)

Study groups in NCT04817436
Study groupRoleWhat they receive
Without adapted physical activity program (APA)Active comparatorNot described
Receives: Other: physical activity program (APA)
With adapted physical activity program (APA)ExperimentalNot described
Receives: Other: physical activity program (APA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To evaluate the effects of adapated physical activity (APA) program on kynurenin metabolism

    Variation of plasmatic kynurenin acid between V1 and V2 in patients undergoing APA during refeeding versus other patients (control group without APA)

    Measured: 3 months

Secondary outcomes (5)
  1. To evaluate the effects of adapated physical activity program on anthropometric data.

    Anthropometric data

    Measured: 3 months

  2. To evaluate the involving of gut microbiota composition and diversity

    gut microbiota analyses

    Measured: 3 months

  3. To evaluate the effects of adapated physical activity program on quality of life

    Self-administered questionnaires assessing the quality of life

    Measured: 3 months

  4. To evaluate the involving of auto-antibodies against neuropeptides involved in food intake regulation

    Dosage of auto-antibodies against neuropeptides involved in food intake regulation using ELISA method (enzyme-linked immunosorbent assay)

    Measured: 3 months

  5. To evaluate the effects of adapated physical activity program on Body composition (fat mass, fat free mass)

    Mesaurement of fat and free mass

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2021
  2. Study start8 Sep 2021
  3. Primary completion8 Sep 2025
  4. Study completion8 Sep 2025

Why it stopped: Diffiulty in enrolling patients

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04817436
Sponsor's protocol ID
2017/383/HP
Acronym
APANOR
Status last verified
Apr 2026
First submitted
25 Jun 2020
Last updated
8 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing physical activity program (APA) in people with Anorexia Nervosa, run by University Hospital, Rouen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Diffiulty in enrolling patients). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To evaluate the effects of adapated physical activity (APA) program on kynurenin metabolism (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in